CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-26 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −3,910 | 1,435,555 | ||
| 2022-10-25 | Schlanger David J Executive Chairman | Exercise or conversion | +25,989 | $0.91 | $24K | 108,537 |
| 2022-10-25 | Schlanger David J Executive Chairman | Sale | −18,500 | $39.48 | $730K | 90,037 |
| 2022-10-25 | Schlanger David J Executive Chairman | Sale | −7,489 | $39.98 | $299K | 82,548 |
| 2022-10-25 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −25,989 | 1,358,680 | ||
| 2022-10-25 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −226 | $38.22 | $9K | 78,953 |
| 2022-10-25 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +32,000 | $3.95 | $126K | 282,445 |
| 2022-10-25 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −23,154 | $39.51 | $915K | 259,291 |
| 2022-10-25 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −8,846 | $39.99 | $354K | 250,445 |
| 2022-10-25 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −5,787 | $39.51 | $229K | 179,788 |
| 2022-10-25 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −2,213 | $39.99 | $88K | 177,575 |
| 2022-10-25 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −2,385 | $41.27 | $98K | 251,570 |
| 2022-10-25 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −32,000 | 1,439,465 | ||
| 2022-10-24 | Payson Norman Director | Grant or award | +3,480 | 12,132 | ||
| 2022-10-24 | Payson Norman Director | Grant or award · Stock Option (Right to Buy) | +15,080 | 15,080 | ||
| 2022-10-24 | SEIDENBERG BETH C Director | Grant or award | +4,060 | 14,154 | ||
| 2022-10-24 | SEIDENBERG BETH C Director | Grant or award · Stock Option (Right to Buy) | +16,820 | 16,820 | ||
| 2022-10-24 | SEIDENBERG BETH C Director | Grant or award · Stock Option (Right to Buy) | +1,898 | 1,898 | ||
| 2022-10-24 | Dean Lloyd H Director | Grant or award | +2,900 | 2,900 | ||
| 2022-10-24 | Dean Lloyd H Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 |
Page 38 of 77 · 1,524 trades